clofibrate has been researched along with eicosapentaenoic acid in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Berthelot, P; Chavatte, P; Desreumaux, P; Farce, A; Furman, C; Lebègue, N; Millet, R; Pirat, C; Renault, N; Speca, S; Yous, S | 1 |
| Fukutake, K; Ishibashi, M; Kojima, M; Masada, A; Mizota, M; Mizuguchi, K; Saito, Y; Sato, M; Tanaka, Y; Yano, T | 1 |
| Bezard, J; Blond, JP; Christiansen, EN; Mimouni, V; Poisson, JP; Ulmann, L | 1 |
| Christensen, E; Christophersen, BO; Grønn, M; Hagve, TA | 1 |
| Fujioka, T; Matsumoto, T; Ueno, T; Watanabe, H | 1 |
2 review(s) available for clofibrate and eicosapentaenoic acid
| Article | Year |
|---|---|
Targeting peroxisome proliferator-activated receptors (PPARs): development of modulators.
Topics: Animals; Humans; Ligands; Metabolic Syndrome; Models, Molecular; Molecular Targeted Therapy; Peroxisome Proliferator-Activated Receptors | 2012 |
[Dyslipidemia in renal failure].
Topics: Arteriosclerosis; Cerebrovascular Disorders; Cholesterol, HDL; Cholesterol, LDL; Clofibrate; Coronary Disease; Eicosapentaenoic Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Kidney Failure, Chronic; Lipoproteins, VLDL; Niceritrol; Peripheral Vascular Diseases; Peritoneal Dialysis, Continuous Ambulatory; Renal Dialysis; Triglycerides | 2004 |
4 other study(ies) available for clofibrate and eicosapentaenoic acid
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Hypolipidemic effect of ethyl all-cis-5,8,11,14,17-eicosapentaenoate (EPA-E) in rats.
Topics: Animals; Cholesterol; Clofibrate; Corn Oil; Dose-Response Relationship, Drug; Eicosapentaenoic Acid; Hypolipidemic Agents; Lipids; Male; Rats; Rats, Inbred Strains | 1992 |
Elongation and desaturation of arachidonic and eicosapentaenoic acids in rat liver. Effect of clofibrate feeding.
Topics: Animals; Arachidonic Acid; Clofibrate; Eicosapentaenoic Acid; Liver; Male; Microsomes, Liver; Mitochondria, Liver; Rats | 1991 |
Peroxisomal retroconversion of docosahexaenoic acid (22:6(n-3)) to eicosapentaenoic acid (20:5(n-3)) studied in isolated rat liver cells.
Topics: Animals; Carnitine; Clofibrate; Docosahexaenoic Acids; Eicosapentaenoic Acid; Fasting; In Vitro Techniques; Kinetics; Liver; Male; Microbodies; Rats; Rats, Inbred Strains; Reference Values | 1991 |